| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTCT over the last quarter tilts toward selling: insiders offloaded a net 112,078 shares worth roughly $7.8M. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.29M | $89.08M | -5,000 | |
| CEO | 383.9K | $26.48M | - | |
| VP | 105.3K | $7.26M | -627 | |
| CFO | 84.0K | $5.79M | - | |
| VP | 79.1K | $5.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2019 | Mark Elliott Boulding56 | Executive VP and CLO | Sale+OE | 181,667 | $45.00 | $8,175,015.00 | -86.0% | |
| Jul 1, 2019 | Christine Marie Utter58 | SVP, Finance & CAO | Sale+OE | 14,059 | $45.14 | $634,602.58 | -74.0% | |
| Jun 3, 2019 | Marcio Souza63 | Chief Operating Officer | Sell | 5,490 | $40.38 | $221,686.20 | -8.6% | |
| Mar 5, 2019 | Christine Marie Utter58 | Principal Financial Officer | Sale+OE | 28,709 | $34.97 | $1,003,824.08 | -85.3% | |
| Jan 25, 2019 | Michael Schmertzler | Director | Buy | 66,225 | $30.20 | $1,999,995.00 | +5.0% | |
| Jan 7, 2019 | Marcio Souza63 | Chief Operating Officer | Sell | 83 | $34.75 | $2,884.25 | -2.9% | |
| Jan 7, 2019 | Neil Gregory Almstead55 | Chief Technical Ops Officer | Sell | 653 | $34.75 | $22,691.75 | -10.4% | |
| Jan 7, 2019 | Christine Marie Utter58 | Principal Financial Officer | Sell | 297 | $34.75 | $10,320.75 | -3.8% | |
| Jan 7, 2019 | Stuart Walter Peltz57 | Chief Executive Officer | Sell | 2,512 | $34.75 | $87,292.00 | -12.5% | |
| Jun 19, 2018 | Neil Gregory Almstead55 | EVP Research Pharma Ops & Tech | Sale+OE | 20,000 | $48.31 | $966,240.00 | -53.8% |